6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide

C112H119N31O8 — CID 158092514

IUPAC6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide
SMILESCc1oncc1-c1cccc(C(=O)Nc2cnccc2N2CCNCC2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2cc[nH]c2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2ccc(CN3CCOCC3)cc2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2ccc(N3CCOCC3)nc2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2cccc3cccnc23)n1
InChIInChI=1S/C26H30N6O2.C24H27N7O2.C24H22N6O.C19H20N6O2.C19H20N6O/c33-26(30-24-18-28-9-8-25(24)32-12-10-27-11-13-32)23-3-1-2-22(29-23)21-6-4-20(5-7-21)19-31-14-16-34-17-15-31;32-24(29-21-17-26-7-6-22(21)30-10-8-25-9-11-30)20-3-1-2-19(28-20)18-4-5-23(27-16-18)31-12-14-33-15-13-31;31-24(29-21-16-26-11-9-22(21)30-14-12-25-13-15-30)20-8-2-7-19(28-20)18-6-1-4-17-5-3-10-27-23(17)18;1-13-14(11-22-27-13)15-3-2-4-16(23-15)19(26)24-17-12-21-6-5-18(17)25-9-7-20-8-10-25;26-19(16-3-1-2-15(23-16)14-4-6-21-12-14)24-17-13-22-7-5-18(17)25-10-8-20-9-11-25/h1-9,18,27H,10-17,19H2,(H,30,33);1-7,16-17,25H,8-15H2,(H,29,32);1-11,16,25H,12-15H2,(H,29,31);2-6,11-12,20H,7-10H2,1H3,(H,24,26);1-7,12-13,20-21H,8-11H2,(H,24,26)
InChIKeyFOGXMNQQMUVHEW-UHFFFAOYSA-N
MW2027.39 g/mol
LogP12.26
Rot. Bonds23

About 6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide

6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide (PubChem CID 158092514) has the molecular formula C112H119N31O8 and a molecular weight of 2027.39 g/mol. Its IUPAC name is 6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide.

Molecular Properties

Compound Name6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide
PubChem CID158092514
Molecular FormulaC112H119N31O8
Molecular Weight2027.39 g/mol
Exact Mass2025.99
IUPAC Name6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide
SMILESCc1oncc1-c1cccc(C(=O)Nc2cnccc2N2CCNCC2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2cc[nH]c2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2ccc(CN3CCOCC3)cc2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2ccc(N3CCOCC3)nc2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2cccc3cccnc23)n1
InChIInChI=1S/C26H30N6O2.C24H27N7O2.C24H22N6O.C19H20N6O2.C19H20N6O/c33-26(30-24-18-28-9-8-25(24)32-12-10-27-11-13-32)23-3-1-2-22(29-23)21-6-4-20(5-7-21)19-31-14-16-34-17-15-31;32-24(29-21-17-26-7-6-22(21)30-10-8-25-9-11-30)20-3-1-2-19(28-20)18-4-5-23(27-16-18)31-12-14-33-15-13-31;31-24(29-21-16-26-11-9-22(21)30-14-12-25-13-15-30)20-8-2-7-19(28-20)18-6-1-4-17-5-3-10-27-23(17)18;1-13-14(11-22-27-13)15-3-2-4-16(23-15)19(26)24-17-12-21-6-5-18(17)25-9-7-20-8-10-25;26-19(16-3-1-2-15(23-16)14-4-6-21-12-14)24-17-13-22-7-5-18(17)25-10-8-20-9-11-25/h1-9,18,27H,10-17,19H2,(H,30,33);1-7,16-17,25H,8-15H2,(H,29,32);1-11,16,25H,12-15H2,(H,29,31);2-6,11-12,20H,7-10H2,1H3,(H,24,26);1-7,12-13,20-21H,8-11H2,(H,24,26)
InChIKeyFOGXMNQQMUVHEW-UHFFFAOYSA-N
XLogP12.26
TPSA443.29 Ų
H-Bond Donors11
H-Bond Acceptors33
Rotatable Bonds23
Heavy Atoms151
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002027.39
LogP ≤ 512.26
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1033

Analyze 6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide?
The IUPAC name of 6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide (CID 158092514) is 6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide.
What is the SMILES notation for 6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide?
The canonical SMILES for 6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide is Cc1oncc1-c1cccc(C(=O)Nc2cnccc2N2CCNCC2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2cc[nH]c2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2ccc(CN3CCOCC3)cc2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2ccc(N3CCOCC3)nc2)n1.O=C(Nc1cnccc1N1CCNCC1)c1cccc(-c2cccc3cccnc23)n1.
What is the InChIKey of 6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide?
The InChIKey is FOGXMNQQMUVHEW-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H30N6O2.C24H27N7O2.C24H22N6O.C19H20N6O2.C19H20N6O/c33-26(30-24-18-28-9-8-25(24)32-12-10-27-11-13-32)23-3-1-2-22(29-23)21-6-4-20(5-7-21)19-31-14-16-34-17-15-31;32-24(29-21-17-26-7-6-22(21)30-10-8-25-9-11-30)20-3-1-2-19(28-20)18-4-5-23(27-16-18)31-12-14-33-15-13-31;31-24(29-21-16-26-11-9-22(21)30-14-12-25-13-15-30)20-8-2-7-19(28-20)18-6-1-4-17-5-3-10-27-23(17)18;1-13-14(11-22-27-13)15-3-2-4-16(23-15)19(26)24-17-12-21-6-5-18(17)25-9-7-20-8-10-25;26-19(16-3-1-2-15(23-16)14-4-6-21-12-14)24-17-13-22-7-5-18(17)25-10-8-20-9-11-25/h1-9,18,27H,10-17,19H2,(H,30,33);1-7,16-17,25H,8-15H2,(H,29,32);1-11,16,25H,12-15H2,(H,29,31);2-6,11-12,20H,7-10H2,1H3,(H,24,26);1-7,12-13,20-21H,8-11H2,(H,24,26).
What are the key properties of 6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide?
6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide has a molecular weight of 2027.39 g/mol, XLogP of 12.26, 23 rotatable bonds, 11 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 6-(5-methyl-1,2-oxazol-4-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-[4-(morpholin-4-ylmethyl)phenyl]-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;6-(6-morpholin-4-yl-3-pyridinyl)-N-(4-piperazin-1-yl-3-pyridinyl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-(1H-pyrrol-3-yl)pyridine-2-carboxamide;N-(4-piperazin-1-yl-3-pyridinyl)-6-quinolin-8-ylpyridine-2-carboxamide is sourced from PubChem (CID 158092514), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).